Ventyx Biosciences, Inc. (VTYX)
NASDAQ: VTYX · Real-Time Price · USD
2.340
-0.110 (-4.49%)
At close: Jun 27, 2025, 4:00 PM
2.380
+0.040 (1.71%)
After-hours: Jun 27, 2025, 7:55 PM EDT
Ventyx Biosciences Market Cap
Ventyx Biosciences has a market cap or net worth of $166.52 million as of June 27, 2025. Its market cap has decreased by -31.33% in one year.
Market Cap
166.52M
Enterprise Value
-51.74M
1-Year Change
-31.33%
Ranking
Category
Stock Price
$2.34
Market Cap Chart
Since the IPO on October 21, 2021, Ventyx Biosciences's market cap has decreased from $782.89M to $166.52M, a decrease of -78.73%. That is a compound annual growth rate of -34.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 174.34M | 12.58% |
| Dec 31, 2024 | 154.86M | 6.21% |
| Dec 29, 2023 | 145.80M | -92.15% |
| Dec 30, 2022 | 1.86B | 85.92% |
| Dec 31, 2021 | 998.89M | 27.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.81B |
| Johnson & Johnson | 365.75B |
| AbbVie | 329.95B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 274.52B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.56B |
| AstraZeneca | 215.99B |